Latest Insider Transactions at Ngm Biopharmaceuticals Inc (NGM)
This section provides a real-time view of insider transactions for Ngm Biopharmaceuticals Inc (NGM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NGM BIOPHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NGM BIOPHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 23
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
30,760
+1.35%
|
$399,880
$13.35 P/Share
|
|
Jul 22
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
30,760
+1.37%
|
$399,880
$13.54 P/Share
|
|
Jul 19
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
6,222
+0.28%
|
$80,886
$13.99 P/Share
|
|
Jul 16
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
3,900
+0.18%
|
$50,700
$13.86 P/Share
|
|
Jul 15
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
16,188
+0.74%
|
$210,444
$13.69 P/Share
|
|
Jul 12
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
21,014
+0.96%
|
$273,182
$13.88 P/Share
|
|
Jul 11
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
10,870
+0.51%
|
$141,310
$13.87 P/Share
|
|
Jun 24
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,240
+0.57%
|
$159,120
$13.78 P/Share
|
|
Jun 21
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
3,763
+0.18%
|
$52,682
$14.03 P/Share
|
|
Jun 20
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
15,400
+0.72%
|
$200,200
$13.86 P/Share
|
|
Jun 19
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
15,214
+0.72%
|
$197,782
$13.91 P/Share
|
|
Jun 14
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
10,760
+0.52%
|
$150,640
$14.0 P/Share
|
|
Jun 13
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
11,500
+0.55%
|
$161,000
$14.13 P/Share
|
|
Jun 12
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
7,500
+0.36%
|
$105,000
$14.0 P/Share
|
|
Jun 11
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
10,900
+0.53%
|
$141,700
$13.83 P/Share
|
|
Jun 07
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.61%
|
$163,800
$13.66 P/Share
|
|
Jun 06
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.62%
|
$163,800
$13.4 P/Share
|
|
Jun 04
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
12,600
+0.62%
|
$163,800
$13.39 P/Share
|
|
May 20
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
50,000
+2.44%
|
$650,000
$13.5 P/Share
|
|
May 10
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
17,923
+0.91%
|
$232,999
$13.85 P/Share
|
|
May 07
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
57,000
+2.87%
|
$798,000
$14.1 P/Share
|
|
Apr 08
2019
|
Column Group L P Director |
BUY
Open market or private purchase
|
Direct |
1,890,000
+50.0%
|
$30,240,000
$16.0 P/Share
|
|
Apr 08
2019
|
Column Group L P Director |
BUY
Conversion of derivative security
|
Direct |
13,093,134
+49.11%
|
-
|
|
Apr 08
2019
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,121,683
+24.14%
|
$65,946,928
$16.0 P/Share
|
|
Apr 08
2019
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
8,833,333
+50.0%
|
-
|